What is the dosage of Keflex (Cephalexin) for skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) Dosage for Skin Infections

For skin infections in adults, Keflex (cephalexin) should be administered at a dose of 500 mg orally four times daily for 5-7 days. 1, 2

Adult Dosing Options

  • Standard regimen: 500 mg orally four times daily (every 6 hours) for 5-7 days 3, 1
  • Alternative regimen: 500 mg orally twice daily (every 12 hours) for uncomplicated skin infections 2
  • Severe infections: May require higher doses up to 4g total daily dose (divided into 4 doses) 2

Pediatric Dosing

  • Standard regimen: 25-50 mg/kg/day divided into 4 doses 2
  • Alternative regimen for streptococcal skin infections: Total daily dose may be divided and administered every 12 hours 2
  • Severe infections: Dosage may be doubled 2

Dosing Based on Weight (Pediatric Suspension)

Using 125 mg/5 mL suspension (4 times daily dosing):

  • 10 kg (22 lb): 1/2 to 1 teaspoon (2.5-5 mL) four times daily
  • 20 kg (44 lb): 1 to 2 teaspoons (5-10 mL) four times daily
  • 40 kg (88 lb): 2 to 4 teaspoons (10-20 mL) four times daily 2

Treatment Duration

  • Uncomplicated skin/soft tissue infections: 5-7 days 1
  • Streptococcal infections: Minimum 10 days to prevent complications 2

Clinical Considerations

Type of Infection

  • Non-purulent infections (cellulitis, erysipelas): Cephalexin is an excellent first-line choice 1
  • Purulent infections (abscesses): Incision and drainage is primary treatment; cephalexin is appropriate if MRSA is not suspected 1

Efficacy

  • Cephalexin has demonstrated high clinical cure rates (87-91%) in clinical trials for skin infections 4, 5
  • Particularly effective against streptococci and methicillin-susceptible Staphylococcus aureus (MSSA) 1

Important Limitations

  • Not effective against MRSA - consider alternative coverage if MRSA is suspected 1
  • Penicillin allergy: Up to 10% of penicillin-allergic patients may also be allergic to cephalosporins; avoid in patients with immediate (anaphylactic-type) hypersensitivity to penicillin 1

Monitoring

  • Reevaluate patient within 48-72 hours to assess treatment response 1
  • Consider hospitalization if no improvement within 24-48 hours of outpatient treatment 1

Special Populations

Renal Impairment

  • Dose adjustment required for patients with creatinine clearance less than 30 ml/min 1

Pregnancy

  • Category B - generally considered safe in pregnancy 3

Common Adverse Effects

  • Diarrhea (most common)
  • Nausea
  • Headache
  • Allergic reactions (rash, pruritus) 4, 5

When to Consider Hospitalization

  • Concern for deeper or necrotizing infection
  • Poor adherence to therapy anticipated
  • Severely immunocompromised patient
  • Outpatient treatment failing (no improvement within 24-48 hours) 1

Cephalexin remains a highly effective first-line option for skin and soft tissue infections, particularly when MRSA is not suspected. The recommended dosing schedule balances efficacy with convenience and tolerability.

References

Guideline

Treatment of Skin and Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.

International journal of clinical practice, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.